The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Protalix BioTherapeutics, Inc(NYSE MKT:PLX) 
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in Israel, Brazil, rest of Latin America, and internationally. The company o...
Website: http://www.protalix.com
Founded: 1993
Full Time Employees: 196
CEO: Dror Bashan
Sector: Healthcare
Industry: Biotechnology
Protalix BioTherapeutics Number of Twitter Followers
Protalix BioTherapeutics Days Payable Outstanding ttm (DPO)
Protalix BioTherapeutics Days Receivable Outstanding ttm (DSO)
Protalix BioTherapeutics Days Inventory Outstanding ttm (DIO)
Protalix BioTherapeutics Op Cashflow Per Share ttm
Protalix BioTherapeutics Free Cashflow Per Share ttm
Protalix BioTherapeutics Cash Per Share ttm
Protalix BioTherapeutics P/S ratio ttm
Protalix BioTherapeutics (GAAP) P/E ratio ttm
Protalix BioTherapeutics P/B ratio ttm
No extra charts and metrics for this ticker.